The Leukotriene Receptor Antagonist Montelukast as a Potential COVID-19 Therapeutic

by Ludwig Aigner, Ludwig Aigner, Ludwig Aigner, Frank Pietrantonio, Diana Marisa Bessa de Sousa, Diana Marisa Bessa de Sousa, Johanna Michael, Johanna Michael, Daniela Schuster, Herbert Anton Reitsamer, Herbert Anton Reitsamer, Horst Zerbe, Michael Studnicka
Published 2020-12-01

The Leukotriene Receptor Antagonist Montelukast Attenuates Neuroinflammation and Affects Cognition in Transgenic 5xFAD Mice

by Johanna Michael, Julia Zirknitzer, Michael Stefan Unger, Rodolphe Poupardin, Tanja Rieß, Nadine Paiement, Horst Zerbe, Birgit Hutter-Paier, Herbert Reitsamer, Ludwig Aigner
Published 2021-03-01

Early functional connectivity deficits and progressive microstructural alterations in the TgF344-AD rat model of Alzheimer’s Disease: A longitudinal MRI study

by Cynthia Anckaerts, Ines Blockx, Priska Summer, Johanna Michael, Julie Hamaide, Christina Kreutzer, Hervé Boutin, Sébastien Couillard-Després, Marleen Verhoye, Annemie Van der Linden
Published 2019-04-01

Improved Bioavailability of Montelukast through a Novel Oral Mucoadhesive Film in Humans and Mice

by Johanna Michael, Diana Bessa de Sousa, Justin Conway, Erick Gonzalez-Labrada, Rodolphe Obeid, Julia Tevini, Thomas Felder, Birgit Hutter-Paier, Horst Zerbe, Nadine Paiement, Ludwig Aigner
Published 2021-12-01